Medicare AdvantageCoverageMedium impact
Magnetic Resonance Angiography (MRA) of the Chest, Abdomen and Pelvis - Medicare Advantage (New)
Humana·Radiology, Cardiology, Vascular Surgery +1 more·Medicare Advantage
Effective date
Jan 2, 2026
We identified it
Jun 24, 2026
Summary
Humana has implemented a new Medicare Advantage policy establishing specific medical necessity criteria for Magnetic Resonance Angiography (MRA) of the chest, abdomen, and pelvis. The policy supplements existing CMS guidance by providing detailed coverage criteria for various vascular conditions, congenital abnormalities, and surveillance imaging across multiple anatomical areas.
Action Required
By January 2, 2026: Billing team must update prior authorization processes for Humana Medicare Advantage MRA claims to align with new medical necessity criteria. Review and document specific indications for chest MRA (congenital arterial disease, aortic syndrome, vascular malformations) and abdomen/pelvis MRA (AAA surveillance, renal stenosis evaluation) before submitting claims. Update encounter forms to prompt providers to document qualifying conditions per the new policy criteria.